Kamat AM - Search Results

1

Smac mimetic reverses resistance to TRAIL and chemotherapy in human urothelial cancer cells.

Metwalli AR, Khanbolooki S, Jinesh G, Sundi D, Shah JB, Shrader M, Choi W, Lashinger LM, Chunduru S, McConkey DJ, McKinlay M, Kamat AM. Metwalli AR, et al. Among authors: kamat am. Cancer Biol Ther. 2010 Nov 1;10(9):885-92. doi: 10.4161/cbt.10.9.13237. Epub 2010 Nov 1. Cancer Biol Ther. 2010. PMID: 20814238 Free PMC article.

2

Nuclear factor-kappaB mediates angiogenesis and metastasis of human bladder cancer through the regulation of interleukin-8.

Karashima T, Sweeney P, Kamat A, Huang S, Kim SJ, Bar-Eli M, McConkey DJ, Dinney CP. Karashima T, et al. Clin Cancer Res. 2003 Jul;9(7):2786-97. Clin Cancer Res. 2003. PMID: 12855659

3

Chemoprevention of superficial bladder cancer.

Kamat AM. Kamat AM. Expert Rev Anticancer Ther. 2003 Dec;3(6):799-808. doi: 10.1586/14737140.3.6.799. Expert Rev Anticancer Ther. 2003. PMID: 14686702 Review.

4

The proteasome inhibitor bortezomib synergizes with gemcitabine to block the growth of human 253JB-V bladder tumors in vivo.

Kamat AM, Karashima T, Davis DW, Lashinger L, Bar-Eli M, Millikan R, Shen Y, Dinney CP, McConkey DJ. Kamat AM, et al. Mol Cancer Ther. 2004 Mar;3(3):279-90. Mol Cancer Ther. 2004. PMID: 15026548

5

Antitumor activity of common antibiotics against superficial bladder cancer.

Kamat AM, Lamm DL. Kamat AM, et al. Urology. 2004 Mar;63(3):457-60. doi: 10.1016/j.urology.2003.10.038. Urology. 2004. PMID: 15028437

6

Focus on bladder cancer.

Dinney CP, McConkey DJ, Millikan RE, Wu X, Bar-Eli M, Adam L, Kamat AM, Siefker-Radtke AO, Tuziak T, Sabichi AL, Grossman HB, Benedict WF, Czerniak B. Dinney CP, et al. Among authors: kamat am. Cancer Cell. 2004 Aug;6(2):111-6. doi: 10.1016/j.ccr.2004.08.002. Cancer Cell. 2004. PMID: 15324694 Free article. Review. No abstract available.

7

Atorvastatin: a potential chemopreventive agent in bladder cancer.

Kamat AM, Nelkin GM. Kamat AM, et al. Urology. 2005 Dec;66(6):1209-12. doi: 10.1016/j.urology.2005.06.075. Urology. 2005. PMID: 16360444

8

Inhibition of bladder tumor growth by 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes: a new class of peroxisome proliferator-activated receptor gamma agonists.

Kassouf W, Chintharlapalli S, Abdelrahim M, Nelkin G, Safe S, Kamat AM. Kassouf W, et al. Among authors: kamat am. Cancer Res. 2006 Jan 1;66(1):412-8. doi: 10.1158/0008-5472.CAN-05-2755. Cancer Res. 2006. PMID: 16397256

9

Controversial issues and optimal management of stage T1G3 bladder cancer.

Metwalli AR, Kamat AM. Metwalli AR, et al. Among authors: kamat am. Expert Rev Anticancer Ther. 2006 Aug;6(8):1283-94. doi: 10.1586/14737140.6.8.1283. Expert Rev Anticancer Ther. 2006. PMID: 16925494 Review.

10

Vitamins C and K3 sensitize human urothelial tumors to gemcitabine.

Kassouf W, Highshaw R, Nelkin GM, Dinney CP, Kamat AM. Kassouf W, et al. Among authors: kamat am. J Urol. 2006 Oct;176(4 Pt 1):1642-7. doi: 10.1016/j.juro.2006.06.042. J Urol. 2006. PMID: 16952707

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

548 results

Search Page

Filters